Tech Nation + BioTech Nation + Global BioEntrepreneurship
image
Weekly Public Radio Program & Podcast
Episode 26-41 Air Date: October 14, 2026
On this week’s Tech Nation, Moira speaks with Stanford Professor of Epidemiology & Population Health, Dr. Michelle Williams, about the history of public health in the United States and how it’s shaped modern society. She says public health is all of our business, and shares more from her book, “The Cure for Everything: The Epic Struggle for Public Health and a Radical Vision for Human Thriving”. Then, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s in trials in the US, but already used by several million patients in Europe for Schizophrenia and other neuropsychiatric conditions. We delve into why the drug couldn’t go straight to approval here, and how they’re working on it.
Episode 26-40Air Date: October 6, 2026
On this week’s Tech Nation, Moira speaks with Dr Shana Kelley, President of Bioengineering and Head of Biohub Chicago, about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr Harry Selker and Dr Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.
Episode 26-39 Air Date: September 29, 2026
On this week’s Tech Nation, Moira speaks with Pediatric surgeon Dr. Dana Suskind about her book, “Human Raised: Nurturing Connection, Curiosity & Lifelong Learning in the Age of AI”, and navigating the unique challenge AI presents for parents. Then, FUJIFILM Biotechnologies Chairman Toshi Iida joins to share how the company has gone way beyond film into the biotech landscape. And, do you ever feel like a virtual meeting isn’t going quite how you expected? Dr. Andrew Brodsky breaks down the science behind virtual communication.
image
BioTech Nation PODCASTS
October 13, 2026
Heather Turner CEO, LB Pharmaceuticals
Dr. Lorn Johnson Interview Podcast
  • This week on Biotech Nation, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s new to the US, but not-so-new to Europe, where it’s already been in use for a couple of years. Intended for managing neuropsychiatric conditions like Schizophrenia, the drug is taken by several million people, but the approval process in the US has had to start back at square one. We look at why that is, and how LB is working on it.

October 6, 2026

Toshihisa "Toshi" Iida Chairman, FUJIFILM Biotechnologies

image
When you think of FUJIFILM, you might be picturing rolls of camera film...but it turns out that's not all they've been working on. FUJIFILM Biotechnologies Chairman Toshi Iida joins to share more about how they're innovating in the world of biotech.
The J.P. Morgan Healthcare Conference 2026
5 Companies Ready to Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
image
image
Industry Insights. Startup Directory. Academic Journal. More Information coming soon.